Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume

Skeletal Radiol. 2000 Oct;29(10):563-71. doi: 10.1007/s002560000276.

Abstract

Purpose: To determine whether T1-weighted magnetic resonance (MR) images can demonstrate response in the marrow of patients with type 1 Gaucher disease treated with enzyme replacement therapy (ERT) and to determine whether a relationship exists between liver and spleen volume reductions and visible marrow changes.

Patients: Forty-two patients with type 1 Gaucher disease were evaluated on at least two occasions. Thirty-two patients received ERT. Of these patients, 15 had a baseline examination prior to the initiation of ERT. The remaining 10 patients did not receive ERT.

Design: T1-weighted and gradient recalled echo (GRE) coronal images of the femurs and hips were obtained. Concurrently, liver and spleen volumes were determined using contiguous breath-hold axial gradient-echo images. T -weighted images of the hips and femurs were evaluated to determine change or lack of change in the yellow marrow.

Results: Of the 32 patients receiving ERT, 14 (44%) demonstrated increased signal on T1-weighted images suggesting an increase in the amount of yellow marrow. If only the 15 patients with a baseline examination were considered, the response rate to ERT was 67%. Using Student's t-test a highly significant correlation (P<0.005) was found between marrow response and reduction in liver and spleen volume.

Conclusions: Marrow changes in patients receiving ERT can be detected by T -weighted images. This response correlated with reductions in visceral volumes (P<0.0005).

MeSH terms

  • Adult
  • Bone Marrow / pathology*
  • Female
  • Femur / pathology
  • Follow-Up Studies
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / pathology*
  • Glucosylceramidase / therapeutic use
  • Hip / pathology
  • Humans
  • Liver / pathology
  • Magnetic Resonance Imaging*
  • Male
  • Spleen / pathology
  • Time Factors

Substances

  • alglucerase
  • Glucosylceramidase
  • imiglucerase